Actos And Bladder Cancer: Takeda Pharmaceutical In Trial

Actos And Bladder Cancer: Takeda Pharmaceutical In Trial

California man Jack Cooper is one of the 3,000 people to file lawsuits against Takeda Pharmaceuticals for a diabetes drug, Actos, and its supposed link to bladder cancer.

Jack Cooper developed bladder cancer due to taking Actos, and is now a plaintiff in the case. A Takeda lawyer, Sara Gourley, explained to a jury in Los Angeles on Tuesday that, “the evidence is not clear,” and proceeded to explain that Mr. Cooper was already a high-risk candidate, saying that he is a diabetic and former smoker. Gourley’s was trying to portray that Takeda Pharmaceuticals is not responsible for the plaintiff’s health condition.

Although Takeda is now blaming Cooper’s bladder cancer on the fact that he is a high-risk patient, the Japan based company hid internal studies since as early as 2004, which linked the drug, Actos, to the development of bladder cancer. The company failed to alert patients and doctors of the risk.

Cooper personally took Actos for over two years, diagnosed with bladder cancer in November 2011. Studies show the longer one takes Actos, the greater risk they have of developing bladder cancer.

It has brought to light that in 2005 and 2006 when the FDA asked Takeda to update the health risks involved with Actos, they managed to continually stall the release of such warnings. It was the pharmaceutical company’s responsibility to disclose all product risks, and they failed to do so.

If you or a loved one has developed bladder cancer after taking Actos for diabetes, call our office at 800.637.8170. Our attorneys want to put an end to pharmaceutical company’s taking advantage of patients only to earn more profits. When you call our office, our attorneys will review your case with you over the phone and decide which steps should be taken toward receiving a favorable settlement.